BACKGROUND: This study sought to determine whether associations exist between perioperative glucose exposure, prolonged hospitalization, and morbid events after complex congenital heart surgery. METHODS AND RESULTS: Metrics of glucose control, including average, peak, minimum, and SD of glucose levels, and duration of hyperglycemia were determined intraoperatively and for 72 hours after surgery for 378 consecutive high-risk cardiac surgical patients. Multivariable regression analyses were used to determine relationships between these metrics of glucose control, hospital length of stay, and a composite morbidity-mortality outcome after controlling for multiple variables known to influence early outcomes after congenital heart surgery. Intraoperatively, a minimum glucose <or=75 mg/dL was associated with greater adjusted odds of reaching the composite morbidity-mortality end point (odds ratio [OR], 3.10; 95% confidence interval [CI], 1.49 to 6.48), but other metrics of glucose control were not associated with the composite end point or length of stay. Greater duration of hyperglycemia (glucose >126 mg/dL) during the 72 postoperative hours was associated with longer duration of hospitalization (P<0.001). In the 72 hours after surgery, average glucose <110 mg/dL (OR, 7.30; 95% CI, 1.95 to 27.25) or >143 mg/dL (OR, 5.21; 95% CI, 1.37 to 19.89), minimum glucose <or=75 mg/dL (OR, 2.85; 95% CI, 1.38 to 5.88), and peak glucose level >or=250 mg/dL (OR, 2.55; 95% CI, 1.20 to 5.43) were all associated with greater adjusted odds of reaching the composite morbidity-mortality end point. CONCLUSIONS: In children undergoing complex congenital heart surgery, the optimal postoperative glucose range may be 110 to 126 mg/dL. Randomized trials of strict glycemic control achieved with insulin infusions in this patient population are warranted.
BACKGROUND: This study sought to determine whether associations exist between perioperative glucose exposure, prolonged hospitalization, and morbid events after complex congenital heart surgery. METHODS AND RESULTS: Metrics of glucose control, including average, peak, minimum, and SD of glucose levels, and duration of hyperglycemia were determined intraoperatively and for 72 hours after surgery for 378 consecutive high-risk cardiac surgical patients. Multivariable regression analyses were used to determine relationships between these metrics of glucose control, hospital length of stay, and a composite morbidity-mortality outcome after controlling for multiple variables known to influence early outcomes after congenital heart surgery. Intraoperatively, a minimum glucose <or=75 mg/dL was associated with greater adjusted odds of reaching the composite morbidity-mortality end point (odds ratio [OR], 3.10; 95% confidence interval [CI], 1.49 to 6.48), but other metrics of glucose control were not associated with the composite end point or length of stay. Greater duration of hyperglycemia (glucose >126 mg/dL) during the 72 postoperative hours was associated with longer duration of hospitalization (P<0.001). In the 72 hours after surgery, average glucose <110 mg/dL (OR, 7.30; 95% CI, 1.95 to 27.25) or >143 mg/dL (OR, 5.21; 95% CI, 1.37 to 19.89), minimum glucose <or=75 mg/dL (OR, 2.85; 95% CI, 1.38 to 5.88), and peak glucose level >or=250 mg/dL (OR, 2.55; 95% CI, 1.20 to 5.43) were all associated with greater adjusted odds of reaching the composite morbidity-mortality end point. CONCLUSIONS: In children undergoing complex congenital heart surgery, the optimal postoperative glucose range may be 110 to 126 mg/dL. Randomized trials of strict glycemic control achieved with insulin infusions in this patient population are warranted.
Authors: Hannah G Piper; Jamin L Alexander; Avinash Shukla; Frank Pigula; John M Costello; Peter C Laussen; Tom Jaksic; Michael S D Agus Journal: Pediatrics Date: 2006-09 Impact factor: 7.124
Authors: Michael G Gaies; Monica Langer; Jamin Alexander; Garry M Steil; Janice Ware; David Wypij; Peter C Laussen; Jane W Newburger; Caren S Goldberg; Frank A Pigula; Avinash C Shukla; Christopher P Duggan; Michael S D Agus Journal: Pediatr Crit Care Med Date: 2013-02 Impact factor: 3.624
Authors: Carmen L Soto-Rivera; Steven M Schwartz; Jaclyn E Sawyer; Duncan J Macrae; Michael S D Agus Journal: Pediatr Crit Care Med Date: 2016-08 Impact factor: 3.624
Authors: Marco Piastra; Alessandro Pizza; Federica Tosi; Sonia Mensi; Luca Massimi; Andrea De Bellis; Daniele G Biasucci; Ersilia Luca; Giorgio Conti; Daniele De Luca Journal: Neurocrit Care Date: 2017-06 Impact factor: 3.210
Authors: Michael S D Agus; Lisa A Asaro; Garry M Steil; Jamin L Alexander; Melanie Silverman; David Wypij; Michael G Gaies Journal: Circulation Date: 2014-03-26 Impact factor: 29.690
Authors: Dániel J Lex; Péter Szántó; Tamás Breuer; Roland Tóth; Mihály Gergely; Zsolt Prodán; Erzsébet Sápi; András Szatmári; Tamás Szántó; János Gál; Andrea Székely Journal: Interv Med Appl Sci Date: 2014-12-22
Authors: Michael S D Agus; Garry M Steil; David Wypij; John M Costello; Peter C Laussen; Monica Langer; Jamin L Alexander; Lisa A Scoppettuolo; Frank A Pigula; John R Charpie; Richard G Ohye; Michael G Gaies Journal: N Engl J Med Date: 2012-09-07 Impact factor: 91.245